Cargando…
Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220552/ https://www.ncbi.nlm.nih.gov/pubmed/29895590 http://dx.doi.org/10.1161/JAHA.118.009151 |
_version_ | 1783368857094717440 |
---|---|
author | Saxena, Manish Shour, Tariq Shah, Mussadiq Wolff, Christopher B. Julu, Peter O. O. Kapil, Vikas Collier, David J. Ng, Fu Liang Gupta, Ajay Balawon, Armida Pheby, Jane Zak, Anne Rull, Gurvinder O'Brien, Benjamin Schmieder, Roland E. Lobo, Melvin D. |
author_facet | Saxena, Manish Shour, Tariq Shah, Mussadiq Wolff, Christopher B. Julu, Peter O. O. Kapil, Vikas Collier, David J. Ng, Fu Liang Gupta, Ajay Balawon, Armida Pheby, Jane Zak, Anne Rull, Gurvinder O'Brien, Benjamin Schmieder, Roland E. Lobo, Melvin D. |
author_sort | Saxena, Manish |
collection | PubMed |
description | BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In this substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension, we enrolled 23 subjects with resistant hypertension. They were randomized either to bilateral renal denervation using therapeutic levels of ultrasound energy (n=12) or sham application of diagnostic ultrasound (n=11). Within‐group changes in autonomic parameters, office and ambulatory blood pressure were compared between baseline and 6 months in a double‐blind manner. There was significant office blood pressure reduction in both treatment (16.1±27.3 mm Hg, P<0.05) and sham groups (27.9±15.0 mm Hg, P<0.01) because of which the study was discontinued prematurely. However, during the late phase II (Iii) of Valsalva maneuver, renal denervation resulted in substantial and significant reduction in mean arterial pressure (21.8±25.2 mm Hg, P<0.05) with no significant changes in the sham group. Moreover, there were significant reductions in heart rate in the actively treated group at rest (6.0±11.5 beats per minute, P<0.05) and during postural changes (supine 7.2±8.4 beats per minute, P<0.05, sit up 12.7±16.7 beats per minute, P<0.05), which were not observed in the sham group. CONCLUSIONS: Blood pressure reduction per se is not necessarily a marker of successful renal nerve ablation. Reduction in splanchnic autotransfusion following renal denervation has not been previously demonstrated and denotes attenuation of (renal) sympathetic efferent activity and could serve as a marker of procedural success. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02029885. |
format | Online Article Text |
id | pubmed-6220552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-62205522018-11-15 Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success Saxena, Manish Shour, Tariq Shah, Mussadiq Wolff, Christopher B. Julu, Peter O. O. Kapil, Vikas Collier, David J. Ng, Fu Liang Gupta, Ajay Balawon, Armida Pheby, Jane Zak, Anne Rull, Gurvinder O'Brien, Benjamin Schmieder, Roland E. Lobo, Melvin D. J Am Heart Assoc Original Research BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In this substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension, we enrolled 23 subjects with resistant hypertension. They were randomized either to bilateral renal denervation using therapeutic levels of ultrasound energy (n=12) or sham application of diagnostic ultrasound (n=11). Within‐group changes in autonomic parameters, office and ambulatory blood pressure were compared between baseline and 6 months in a double‐blind manner. There was significant office blood pressure reduction in both treatment (16.1±27.3 mm Hg, P<0.05) and sham groups (27.9±15.0 mm Hg, P<0.01) because of which the study was discontinued prematurely. However, during the late phase II (Iii) of Valsalva maneuver, renal denervation resulted in substantial and significant reduction in mean arterial pressure (21.8±25.2 mm Hg, P<0.05) with no significant changes in the sham group. Moreover, there were significant reductions in heart rate in the actively treated group at rest (6.0±11.5 beats per minute, P<0.05) and during postural changes (supine 7.2±8.4 beats per minute, P<0.05, sit up 12.7±16.7 beats per minute, P<0.05), which were not observed in the sham group. CONCLUSIONS: Blood pressure reduction per se is not necessarily a marker of successful renal nerve ablation. Reduction in splanchnic autotransfusion following renal denervation has not been previously demonstrated and denotes attenuation of (renal) sympathetic efferent activity and could serve as a marker of procedural success. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02029885. John Wiley and Sons Inc. 2018-06-12 /pmc/articles/PMC6220552/ /pubmed/29895590 http://dx.doi.org/10.1161/JAHA.118.009151 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Saxena, Manish Shour, Tariq Shah, Mussadiq Wolff, Christopher B. Julu, Peter O. O. Kapil, Vikas Collier, David J. Ng, Fu Liang Gupta, Ajay Balawon, Armida Pheby, Jane Zak, Anne Rull, Gurvinder O'Brien, Benjamin Schmieder, Roland E. Lobo, Melvin D. Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title | Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title_full | Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title_fullStr | Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title_full_unstemmed | Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title_short | Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success |
title_sort | attenuation of splanchnic autotransfusion following noninvasive ultrasound renal denervation: a novel marker of procedural success |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220552/ https://www.ncbi.nlm.nih.gov/pubmed/29895590 http://dx.doi.org/10.1161/JAHA.118.009151 |
work_keys_str_mv | AT saxenamanish attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT shourtariq attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT shahmussadiq attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT wolffchristopherb attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT julupeteroo attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT kapilvikas attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT collierdavidj attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT ngfuliang attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT guptaajay attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT balawonarmida attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT phebyjane attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT zakanne attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT rullgurvinder attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT obrienbenjamin attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT schmiederrolande attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess AT lobomelvind attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess |